The reading library /

Product review · Published October 7, 2026 · Updated October 7, 2026

Hims Tadalafil + Vardenafil Hard Mints review

Hims Tadalafil + Vardenafil Hard Mints: two PDE5 inhibitors, including vardenafil, with formulation, cost, evidence and availability examined to audit what the offer actually establishes.

Public-document editorial research · No clinician sign-off or firsthand treatment testing. Source access dates appear with each reference.

An offer becomes easier to examine when it has a precise subject. Here that subject is Hims Tadalafil + Vardenafil Hard Mints: a tadalafil/vardenafil mint described in Hims safety information. The review separates the company's product description from clinical evidence and from the terms of a personal order. Those records support different conclusions, even when they appear together on a sales page.

The exact product

The identifying feature is two PDE5 inhibitors, including vardenafil. A general company review cannot resolve that distinction because the same seller may offer several preparations. Read the active list, form and schedule as separate fields. If the pharmacy's eventual label differs from the public description, the supplied prescription needs its own explanation. Familiar ingredients do not establish that every finished formulation shares the approval or evidence of an approved tablet.

DetailRecord
ProviderHims
Listed active ingredientsTadalafil + vardenafil
Dosage formCompounded combination mint
Regulatory distinctionCompounded preparation; the finished product is not FDA-approved.
Source basisHims: Hard Mints formulation safety library · Hims: current ED treatment catalog

Price, supply and payment

The advertised entry is Current plan price not verified. An offer audit asks what must be true for that figure to apply: which medicine, strength, count, billing interval and customer eligibility. The record below retains the details that were actually published. It does not fill gaps by multiplying unrelated unit and monthly banners. Ask for a complete current quote, including the renewal and any charge triggered by changing treatment.

DetailRecord
Public documentationHard Mints formulation safety library
Current priceNot verified for a matching selectable plan
Not 3-in-1 Hard MintsDifferent PDE5 pair from sildenafil/tadalafil/B12
Additional assessmentVardenafil makes rhythm-history review relevant

What the research can support

The evidence trace leads to individual-drug information; sildenafil/tadalafil studies do not test this pair. It does not establish finished-product comparative evidence and account availability. A provider citation is not enough by itself; the cited intervention and outcome must fit the advertised conclusion. A study of a different regimen or route can inform a question while leaving the finished-product claim unproven. This review therefore avoids patient-outcome scores and claims of comparative superiority that the records do not support.

DetailRecord
Evidence boundaryindividual-drug information; sildenafil/tadalafil studies do not test this pair
Not established herefinished-product comparative evidence and account availability
Clinical and regulatory referencesMedlinePlus: Vardenafil · Cui et al. (2015): daily tadalafil with as-needed sildenafil · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Compounding and the FDA — questions and answers · MedlinePlus: Sildenafil · MedlinePlus: Tadalafil

Safety questions for the prescriber

The safety record cannot be replaced by a low price or a rapid-onset headline. A prescriber needs the complete history, especially nitrates or nitrites, riociguat, other ED medicines and blood-pressure treatment. Relevant cardiovascular, kidney, liver and eye conditions matter too. Do not independently overlap Hims Tadalafil + Vardenafil Hard Mints with another product or treat a prior prescription as permission to create a new combination.

DetailRecord
Multiple PDE5 inhibitorsStandard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed.
VardenafilQT/rhythm history and interacting medicines need explicit review.

Availability and the actual prescription

Our access finding is Documented in the safety library; current sale availability unverified. A current-looking document may describe a formulation without offering a matching new-customer plan. Record that distinction before comparing prices. State or account eligibility, prescribing approval and dispensing are separate stages, and none is verified by the presence of a product name in a public article. A complete offer should explain which conditions apply to the individual order.

Refills, changes and cancellation

Review the exit and adjustment terms with the entry price. Find the notice deadline, the processing point after which an order cannot be stopped, and the channel for medication questions. The specific clinical issue to raise is “What evidence and monitoring support this specific two-drug combination?” Keep the clinician's answer separate from a support explanation of billing. Canceling future supply does not establish a refund for a processed order or a safe plan for changing medication.

DetailRecord
Next chargeThe next order date is the charge/processing date; a first refill can be scheduled early.
Cancellation noticeAt least 48 hours before the next order, according to support guidance.
Already processingEnding a subscription does not cancel an order already processing or shipped.
Refund boundaryNo refund guaranteed after pharmacy processing.
Policy sourcesHims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs

Compare named products

The linked reviews expose differences that a brand-level comparison can hide. Compare a verified ingredient field or a complete price configuration rather than an overall reputation. Where an alternative lacks a current quote, the limitation is part of the result. A source-backed review can clarify an offer without declaring a best treatment for everyone or presenting provider marketing as independent clinical evidence.

Questions to keep with the offer

The inspection boundary is narrow and explicit: public documents for Hims Tadalafil + Vardenafil Hard Mints, checked on the stated date. We did not complete a purchase, test a sample, audit prescribing or measure patient response. References below let readers examine the claims themselves. Unanswered product and payment questions should remain visible until the responsible clinical or support team provides the missing information.

DetailRecord
Ask about this formulaWhat evidence and monitoring support this specific two-drug combination?
Ask about the paymentWhat are the exact quantity, total due now, renewal amount and notice deadline?
Ask about a changeWho confirms the medical instructions, pharmacy order and next account charge?

When to get urgent help

An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.

Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.

Original sources

These documents support different kinds of statements. A provider page records an advertised offer; medical and regulatory records need their own exact-product context.

  1. Hims: Hard Mints formulation safety libraryProvider formulation document; includes options not confirmed in the main catalog · Checked 2026-10-07
  2. Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices · Checked 2026-10-07
  3. MedlinePlus: VardenafilGovernment patient drug information; standard products, not compounded equivalents · Checked 2026-10-07
  4. Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing · Checked 2026-10-07
  5. Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing · Checked 2026-10-07
  6. Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals · Checked 2026-10-07
  7. Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation · Checked 2026-10-07
  8. Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI · Checked 2026-10-07
  9. DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07
  10. FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications · Checked 2026-10-07
  11. MedlinePlus: SildenafilDrug information; standard sildenafil products · Checked 2026-10-07
  12. MedlinePlus: TadalafilDrug information; standard tadalafil products · Checked 2026-10-07